Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
22.2M
-
Number of holders
-
456
-
Total 13F shares, excl. options
-
18.5M
-
Shares change
-
-126K
-
Total reported value, excl. options
-
$6.61B
-
Value change
-
-$70.1M
-
Put/Call ratio
-
1.09
-
Number of buys
-
192
-
Number of sells
-
-234
-
Price
-
$358.45
Significant Holders of BIO-RAD LABORATORIES, INC. - Common (BIO) as of Q3 2023
530 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Common as of Q3 2023.
BIO-RAD LABORATORIES, INC. - Common (BIO) has 456 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.5M shares
of 22.2M outstanding shares and own 83.22% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.34M shares), BlackRock Inc. (1.44M shares), Veritas Asset Management LLP (1.11M shares), BROWN ADVISORY INC (956K shares), STATE STREET CORP (859K shares), UBS ASSET MANAGEMENT AMERICAS INC (575K shares), BANK OF AMERICA CORP /DE/ (497K shares), GEODE CAPITAL MANAGEMENT, LLC (452K shares), ALLIANCEBERNSTEIN L.P. (435K shares), and MILLENNIUM MANAGEMENT LLC (377K shares).
This table shows the top 456 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.